Detailed information for compound 587424

Basic information

Technical information
  • TDR Targets ID: 587424
  • Name: acridine-9-carbaldehyde
  • MW: 207.227 | Formula: C14H9NO
  • H donors: 0 H acceptors: 2 LogP: 2.99 Rotable bonds: 1
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=Cc1c2ccccc2nc2c1cccc2
  • InChi: 1S/C14H9NO/c16-9-12-10-5-1-3-7-13(10)15-14-8-4-2-6-11(12)14/h1-9H
  • InChiKey: ISOCABSXIKQOOV-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 9-acridinecarboxaldehyde
  • 885-23-4
  • 9-acridinecarbaldehyde
  • AQ-344/09638033
  • 9-Acridinealdehyde
  • 9-Formylacridine
  • Acridine, 9-formyl-
  • NSC158261
  • 9-Acridine carboxaldehyde
  • 9-Acridinecarboxaldehyde (8CI)(9CI)
  • NSC 158261
  • ZINC04100749

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0046 0.2636 0.2636
Loa Loa (eye worm) glutathione reductase 0.0048 0.2744 0.3519
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0121 0.7834 1
Brugia malayi dihydrolipoyl dehydrogenase, mitochondrial precursor, putative 0.0017 0.0578 0.0742
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0046 0.2636 0.9606
Mycobacterium tuberculosis Probable dehydrogenase 0.0109 0.699 0.8837
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0046 0.2636 0.338
Echinococcus multilocularis dihydrolipoamide dehydrogenase 0.0017 0.0578 0.2108
Trypanosoma brucei trypanothione reductase 0.0048 0.2744 1
Plasmodium falciparum thioredoxin reductase 0.0048 0.2744 1
Echinococcus multilocularis thioredoxin glutathione reductase 0.0048 0.2744 1
Brugia malayi alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase 0.0012 0.0274 0.0351
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0046 0.2636 0.338
Trichomonas vaginalis glutathione reductase, putative 0.0017 0.0578 0.5
Schistosoma mansoni dihydrolipoamide dehydrogenase 0.0017 0.0578 0.0578
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0017 0.0578 0.5
Brugia malayi glutathione reductase 0.0048 0.2744 0.3519
Treponema pallidum NADH oxidase 0.0017 0.0578 0.5
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0109 0.699 0.8837
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0046 0.2636 0.2636
Plasmodium falciparum glutathione reductase 0.0048 0.2744 1
Mycobacterium ulcerans flavoprotein disulfide reductase 0.0017 0.0578 0.5
Brugia malayi MH2 domain containing protein 0.0121 0.7798 1
Loa Loa (eye worm) thioredoxin reductase 0.0048 0.2744 0.3519
Brugia malayi Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein 0.0012 0.0274 0.0351
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0046 0.2636 0.2636
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0121 0.7834 1
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0109 0.699 0.8837
Brugia malayi Thioredoxin reductase 0.0048 0.2744 0.3519
Mycobacterium ulcerans dihydrolipoamide dehydrogenase 0.0017 0.0578 0.5
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0048 0.2744 0.2985
Toxoplasma gondii thioredoxin reductase 0.0048 0.2744 1
Mycobacterium tuberculosis Probable oxidoreductase 0.0121 0.7834 1
Mycobacterium ulcerans dihydrolipoamide dehydrogenase, LpdB 0.0017 0.0578 0.5
Leishmania major trypanothione reductase 0.0048 0.2744 1
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0109 0.699 0.8837
Trypanosoma cruzi trypanothione reductase, putative 0.0048 0.2744 1
Plasmodium vivax glutathione reductase, putative 0.0048 0.2744 1
Loa Loa (eye worm) MH2 domain-containing protein 0.0121 0.7798 1
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0109 0.699 0.8837
Echinococcus granulosus dihydrolipoamide dehydrogenase 0.0017 0.0578 0.2108
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0121 0.7834 1
Giardia lamblia NADH oxidase lateral transfer candidate 0.0017 0.0578 0.5
Loa Loa (eye worm) transcription factor SMAD2 0.0121 0.7798 1
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0017 0.0578 0.5
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0046 0.2636 0.9606
Trichomonas vaginalis mercuric reductase, putative 0.0017 0.0578 0.5
Mycobacterium tuberculosis Probable reductase 0.0109 0.699 0.8837
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0046 0.2636 0.9606
Plasmodium vivax thioredoxin reductase, putative 0.0048 0.2744 1
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0017 0.0578 0.5
Echinococcus granulosus thioredoxin glutathione reductase 0.0048 0.2744 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0046 0.2636 0.9606

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.